SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

NCT00997061 · clinicaltrials.gov ↗

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer, Small Cell

Interventions

DRUG: HYCAMTIN

Sponsor

GlaxoSmithKline